Vinflunine: Discovery and Synthesis of a Novel Microtubule Inhibitor

Seminars in Oncology

Volumn 35, Issue SUPPL 3, 2008, Pages S3-

  Fahy, Jacques ^a   Hellier, Paul ^a   Breillout, Fabienne ^a   Bailly, Christian ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NAVELBINE; VELBANAMINE; VINBLASTINE; VINCA ALKALOID; VINFLUNINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RESEARCH; CHEMICAL REACTION; CLINICAL TRIAL; DRUG CONFORMATION; DRUG POTENCY; DRUG STRUCTURE; DRUG TRANSFORMATION; HUMAN; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 44449142499     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.01.004     Document Type: Article

References (18)

1. Jordan M.A., and Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4 (2004) 253-265
2. Hait W.N., Rubin E., and Goodin S. Tubulin-targeting agents. Cancer Chemother Biol Response Modif 22 (2005) 35-59
3. Rowinsky E.K., and Tolcher A. Antimicrotubule agents. In: DeVita Jr. V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer principles & practice of oncology. 7th ed. (2005), Lippincott Williams & Wilkins, Philadelphia, PA 390-416
4. Noble R.L., Beer C.T., and Cutts J.H. Further biological activities of vincaleukoblastine-an alkaloid isolated from Vinca rosea (L.). Biochemical Pharmacology 1 (1958) 347-357
5. Gidding C.E., Kellie S.J., Kamps W.A., and De Graaf S.S. Vincristine revisited. Crit Rev Oncol Hematol 29 (1999) 267-287
6. Johnson S.A., Harper P., Hortobagyi G.N., and Pouillart P. Vinorelbine: an overview. Cancer Treat Rev 22 (1996) 127-142
7. Duflos A., Kruczynski A., and Barret J.M. Novel aspects of natural and modified vinca alkaloids. Curr Med Chem Anticancer Agents 2 (2002) 55-70
8. Hill B. Superior in vivo experimental antitumor activity of vinflunine, relative to vinorelbine, in a panel of human tumor xenografts. Eur J Cancer 35 (1999) 512-520
9. Kruczynski A., Colpaert F., Tarayre J.P., Mouillard P., Fahy J., and Hill B.T. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid. Cancer Chemother Pharmacol 41 (1998) 437-447
10. Krzakowski M. Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen. J Clin Oncol. 25(18S):387 (abstr 7511).
11. Olah G.A. Crossing conventional boundaries in half a century of research. J Org Chem 70 (2005) 2413-2419
12. Jacquesy J.C., and Fahy J. Cancer: superacid generation of new antitumor agents. In: Torrence P.F. (Ed). Biomedical chemistry; applying chemical principles to the understanding and treatment of disease (2000), Wiley-Interscience, New York, NY 227-246
13. Fahy J. Modifications in the "upper" velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities. Curr Pharm Des 7 (2001) 1181-1197
14. Fahy J., Duflos A., Ribet J.P., Jacquesy J.C., Berrier C., Jouannetaud M.P., et al. Vinca alkaloids in superacidic media: a method for creating a new family of antitumor derivatives. J Am Chem Soc 119 (1997) 8576-8577
15. Mangeney P., Andriamialisoa R.Z., Lallemand J.Y., Langlois N., Langlois Y., and Potier P. 5′-nor anhydrovinblastine, prototype of a new class of vinblastine derivatives. Tetrahedron 35 (1979) 2175-2179
16. Ribet J.P., Zalavari P., Fahy J., Duflos A., and Beltran T. Complete assignment of 1H and 13C NMR spectra of vinflunine. Mag Res Chem 39 (2001) 43-48
17. Fabre C., Czaplicki J., Wright M., Hill B., Barret J.M., Fahy J., et al. Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analyses. Biochem Pharmacol 64 (2002) 733-740
18. Lobert S., Fahy J., Hill B.T., Duflos A., Etievant C., and Correia J.J. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Biochemistry 39 (2000) 12053-12062